< Back

November/December 2007, vol.9, no.6
Notable gender & racial disparities exist among clinical investigators
View summary    Purchase single issue

September/October 2007, vol.9, no.5
Despite more cancer drugs in R&D, overall U.S. approval rate is 8%
View summary    Purchase single issue

July/August 2007, Vol. 9, No. 4
Follow-on drugs and indications play key role for World Health Organization
View summary    Purchase single issue

May/June 2007, Vol. 9, No. 3
Challenges loom for postmarketing study commitments; benefits unclear
View summary    Purchase single issue

March/April 2007 Vol. 9, No. 2
Pediatric Study Costs Rose Substantially from 2000 as Complexity Grew
View summary    Purchase single issue

January/February 2007 Vol.9 No.1
EMEA meets performance goals, but lags U.S. FDA in drug approvals
View summary    Purchase single issue